Genmab (CPH:GEN)

Company Profile

Genmab (OMX: GEN) is an international biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. It has a co-development and commercialization agreement with GSK.

Company Info

  • HQ: Copenhagen, Denmark
Founders and CEO:
  • Lisa Drakeman
Index Team:
Website:
genmab.com
Sector:
Healthcare
Status:
Exited